Abstract
Jing Miao, Jinfang Cheng, Jiheng Yuan, Linlin Gao
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Diabetes: a defining disease of the 21st century
10.1016/s0140-6736(23)01296-5 · 2023
11th edition of the IDF diabetes atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050
10.1016/s2213-8587(25)00299-2 · 2026
5. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes-2026
10.2337/dc26-s005 · 2026
Interorgan metabolic crosstalk in human insulin resistance
10.1152/physrev.00015.2017 · 2018
Metabolomics, physical activity, exercise and health: a review of the current evidence
10.1016/j.bbadis.2020.165936 · 2020
Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications
10.1016/j.lfs.2018.09.035 · 2018
The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia
10.1016/j.cmet.2021.03.020 · 2021
Hormonal regulation of hepatic glucose production in health and disease
10.1016/j.cmet.2011.06.003 · 2011
Integrative metabolomics of targeted and nontargeted analyses in T2D progression
10.2337/dc25-1707 · 2026
Plasma lactate as a marker for metabolic health
10.1249/jes.0000000000000220 · 2020
Lactate and risk of incident diabetes in a case-cohort of the atherosclerosis risk in communities (ARIC) study
10.1371/journal.pone.0055113 · 2013
Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance
10.1016/j.cmet.2007.10.013 · 2008
Impaired TCA cycle flux in mitochondria in skeletal muscle from type 2 diabetic subjects: marker or maker of the diabetic phenotype
10.3109/13813455.2012.656653 · 2012
Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus
10.1146/annurev-nutr-071715-050656 · 2016
Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis
10.2337/dc15-2251 · 2016
Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome
10.1016/s2213-8587(13)70143-8 · 2014
Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach
10.2337/db13-0570 · 2013
Metabolite profiles and the risk of developing diabetes
10.1038/nm.2307 · 2011
Divergent survival outcomes associated with elevated branched-chain amino acid levels among older adults with or without hypertension and diabetes: a validated, prospective, longitudinal follow-up study
10.3390/biom13081252 · 2023
Bidirectional modulation of insulin action by amino acids
10.1172/jci1326 · 1998
Interplay between lipids and branched-chain amino acids in development of insulin resistance
10.1016/j.cmet.2012.01.024 · 2012
Regulatory effects and mechanisms of branched chain amino acids and metabolic intermediates on insulin resistance
10.13294/j.aps.2023.0023 · 2023
Metabolomics of type 2 diabetes mellitus in sprague dawley rats-in search of potential metabolic biomarkers
10.3390/ijms241512467 · 2023
Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state
10.3945/an.111.000737 · 2011
Plasma amino acid levels and insulin secretion in obesity
10.1056/nejm196910092811503 · 1969
Phenylalanine homeostasis in metabolic disorders: epidemiological trends, pathophysiological mechanisms, and clinical treatment
10.3389/fendo.2026.1814249 · 2026
Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach
10.2337/db12-0495 · 2013
Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS
10.1007/s00125-016-4069-2 · 2016
Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose
10.1007/s00125-018-4599-x · 2018
Glycolysis/gluconeogenesis- and tricarboxylic acid cycle-related metabolites, mediterranean diet, and type 2 diabetes
10.1093/ajcn/nqaa016 · 2020
Metabolomics and type 2 diabetes risk: an updated systematic review and meta-analysis of prospective cohort studies
10.2337/dc21-1705 · 2022
High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: case-cohort study within the predimed trial
10.1016/j.numecd.2019.06.005 · 2019
Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults
10.2337/dc12-0895 · 2013
The pivotal role of the western diet, hyperinsulinemia, ectopic fat, and diacylglycerol-mediated insulin resistance in type 2 diabetes
10.3390/ijms26189191 · 2025
L-carnitine and acylcarnitines: mitochondrial biomarkers for precision medicine
10.3390/metabo11010051 · 2021
The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
10.1016/s0140-6736(63)91500-9 · 1963
Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in finnish men
10.2337/dc13-0800 · 2013
Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation
10.1186/s12967-025-06341-5 · 2025
Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid β-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-american women
10.3945/jn.108.103754 · 2009
Plasma acylcarnitines and risk of type 2 diabetes in a mediterranean population at high cardiovascular risk
10.1210/jc.2018-01000 · 2019
Altered asparagine and glutamate homeostasis precede coronary artery disease and type 2 diabetes
10.1210/jc.2018-00546 · doi-reference
Large-scale association analyses identify host factors influencing human gut microbiome composition
10.1038/s41588-020-00763-1 · doi-reference
Shared and distinct metabolomics profiles associated with microvascular complications in the diabetes prevention program outcomes study
10.1007/s00125-025-06571-8 · doi-reference
Unveiling biomarkers via plasma metabolome profiling for diabetic macrovascular and microvascular complications
10.1186/s12933-025-02899-y · doi-reference
Metabolite concentration changes in humans after a bout of exercise: a systematic review of exercise metabolomics studies
10.1186/s40798-020-0238-4 · doi-reference
Metabolomic profiling of intensity-dependent responses to acute exercise in healthy humans
10.1186/s12967-026-07937-1 · doi-reference
PLIS: a metabolomic response monitor to a lifestyle intervention study in older adults
10.1096/fj.202201037r · doi-reference
Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness
10.1007/s00125-014-3343-4 · doi-reference
Research advances in the application of metabolomics in exercise science
10.3389/fphys.2023.1332104 · doi-reference
Gut microbiome-adipose crosstalk modulates soluble IL-6 receptor influencing exercise responsiveness in glycemic control and insulin sensitivity
10.1016/j.cmet.2025.10.013 · doi-reference
Muscle-saturated bioactive lipids are increased with aging and influenced by high-intensity interval training
10.3390/ijms20051240 · doi-reference
Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in american indians
10.1172/jci.insight.130317 · doi-reference
Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations
10.1038/s41598-018-33507-7 · doi-reference
β-Hydroxybutyrylation links ketone metabolism to mitochondrial remodeling in diabetic cardiomyopathy
10.2337/db25-0496 · doi-reference
Metabolomic biomarkers in vitreous humor: unveiling the molecular landscape of diabetic retinopathy progression
10.1186/s40942-025-00682-5 · doi-reference
Novel type 2 diabetes prediction score based on traditional risk factors and circulating metabolites: model derivation and validation in two large cohort studies
10.1016/j.eclinm.2024.102971 · doi-reference
Metabolomics and metabolic diseases: where do we stand
10.1016/j.cmet.2016.09.018 · doi-reference
Metabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs
10.3389/fendo.2023.1237934 · doi-reference
Metabolomics uncovers the diabetes metabolic network: from pathophysiological mechanisms to clinical applications
10.3389/fendo.2025.1624878 · doi-reference
Analysis types and quantification methods applied in UPLC-MS metabolomics research: A tutorial
10.1007/s11306-024-02155-6 · doi-reference
A roadmap for interpreting 13C metabolite labeling patterns from cells
10.1016/j.copbio.2015.02.003 · doi-reference
Establishment and application of a knowledge-directed pseudo-targeted analytical method for diabetic retinopathy
10.3724/sp.j.1123.2025.02011 · doi-reference
Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry
10.1021/ac4016787 · doi-reference
Divergent skeletal muscle metabolomic signatures of different exercise training modes independently predict cardiometabolic risk factors
10.2337/db23-0142 · doi-reference
Effect of acute exercise and exercise training on the ability of insulin to clear branched-chain amino acids from plasma in obesity and type 2 diabetes
10.1007/s00125-025-06454-y · doi-reference
Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices
10.1038/s41592-021-01197-1 · doi-reference
Untargeted metabolomics strategies-challenges and emerging directions
10.1007/s13361-016-1469-y · doi-reference
Precision exercise in type 2 diabetes mellitus: targeting signaling networks for lipid homeostasis
10.3390/metabo16040269 · doi-reference
Metabolomics in diabetes and diabetic complications: insights from epidemiological studies
10.3390/cells10112832 · doi-reference
Circulating metabolites, genetics and lifestyle factors in relation to future risk of type 2 diabetes
10.1038/s41591-025-04105-8 · doi-reference
Metabolomics: beyond biomarkers and towards mechanisms
10.1038/nrm.2016.25 · doi-reference
Metabolomics for investigating physiological and pathophysiological processes
10.1152/physrev.00035.2018 · doi-reference
Innovation: Metabolomics: the apogee of the omics trilogy
10.1038/nrm3314 · doi-reference
Metformin and exercise effects on postprandial insulin sensitivity and glucose kinetics in pre-diabetic and diabetic adults
10.1152/ajpendo.00118.2023 · doi-reference
Mechanism underlying the effects of exercise against type 2 diabetes: a review on research progress
10.4239/wjd.v15.i8.1704 · doi-reference
Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC-1α: implications for metabolic disease
10.1139/h07-083 · doi-reference
Metabolomic profiling reveals that exercise lowers biomarkers of cardiac dysfunction in rats with type 2 diabetes
10.3390/antiox13101167 · doi-reference
The effect of high-intensity interval training on type 2 diabetic muscle: a metabolomics-based study
10.1016/j.heliyon.2024.e34917 · doi-reference
Metabolomics studies on db/db diabetic mice in skeletal muscle reveal effective clearance of overloaded intermediates by exercise
10.1016/j.aca.2017.11.082 · doi-reference
Quantitative biological study of exercise intervention on type 2 diabetes mellitus rats based on serum metabonomics
10.16237/j.cnki.cn44-1404/g8.2016.04.018 · doi-reference